[1]李金丽,邢力刚.FDG肿瘤显像相关分子机制研究进展[J].国际放射医学核医学杂志,2003,27(3):111-114.
　LI Jin-li,XING Li-gang.Progression of molecular mechanisms of tumor 18F-FDG PET imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(3):111-114.
点击复制

FDG肿瘤显像相关分子机制研究进展(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
27
期数:
2003年第3期
页码:
111-114
栏目:
综述
出版日期:
1900-01-01

文章信息/Info

Title:
Progression of molecular mechanisms of tumor 18F-FDG PET imaging
作者:
李金丽1;  邢力刚2
1. 250117 济南, 山东省肿瘤医院放疗科;
2. 300053 天津, 天津医科大学
Author(s):
LI Jin-li1;  XING Li-gang2
1. Department of Radiation Oncology, Shandong Tumour Hospital and Institute, Ji’nan 250117, China;
2. Tianjin Medical University, Tianjin 300052, China
关键词:
分子机制; 脱氧葡萄糖; 正电子发射体层显像
Keywords:
mechanisms; deoxyglucose; positron emission tomography
分类号:
R817.4
摘要:
18F-FDG(18F-氟代脱氧葡萄糖)PET显像是依靠不同组织对18F-FDG的吸收差异来完成的,18F-FDG在肿瘤中的摄取增高与肿瘤的代谢及增殖情况、病理分级、分化程度、细胞的增生活性、倍增时间等生物学特性密切相关。进一步研究FDG吸收机制,将有助于对肿瘤的生物学特性更深一步的了解。
Abstract:
18F-FDG (18F-fluorodeoxyglucose) PET imaging depends on different uptake of 18F-FDG in different tissues.The uptake of 18F-FDG in tumor tissue correlates with tumor’s biologic behavours, such as metabolism, proliferating, pathologic stage, differentiation, the proliferating acitivity of cells and double times. With more knowlegement of the mechanisms of 18F-FDG uptake, weU know more about tumour’s biologic behavours.

参考文献/References:

[1] Chung JK, Lee YJ, Kim C, et al. Mechanisms related to[F-18] fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice[J]. J Nucl Med, 1999, 40:339-346.
[2] Higashi K, Ueda Y, Sakurai A, et al. Correlation of Glut-1 glucose transporter expression with[18F] FDG uptake in non-small cell lung cancer[J]. Eur J Nucl Med, 2000, 27(12):1778-1785.
[3] Pedersen MW, Holm S, Lund EL, et al. Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and vitro[J]. Neoplasia, 2001, 3(1):80-87.
[4] Schelling M, Avril N, Nahrig J, et al. Positron emission tomography using[18F] Fluorodexoxyglucose for monitoring primary chemotherapy in breast cancer[J]. J Clin Oncol, 2000, 18:1689-1695.
[5] Aloj L, Carco C, Jagoda E, et al. Glut-1 and hexokinase expression:relationship with 2-Fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture[J]. Cancer Res, 1999,59:4709-4714.
[6] Marom EM, Aloia TA, Moore MB, et al. Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer[J]. Lung Cancer,2001,33(2-3):99-107.
[7] Avril N, Menzel M, Dose J, et al. Glucose metabolism of breast cancer assessed by 18F-FDG PET:histologic and im-munohistochemical tissue analysis[J]. J Nucl Med, 2001, 42(1):9-16.
[8] Mochizuki T, Tsukamoto E, Kuge Y, et al. FDG uptake and glucose transporter subtype expression in experimental tumor and inflammation models[J]. J Nucl Med, 2001, 42:1551-1555.
[9] Smith TAD, Titley J. Deoxyglucose uptake by a head and neck squamous carcinoma:influence of changes in proliferative fraction[J]. Int J Radiat Oncol Biol Phys, 2000, 47(1):219-223.
[10] Higashi K, Ueda Y, Yagishita M, et al. FDG PET measurement of the proliferative potential of non-small cell lung cancer[J]. J Nucl Med, 2000, 41(1):85-92.
[11] Vesselle H, Schmidt RA, Pugsley JM, et al. Lung cancer proliferation correlation with[F-18] fluorodexuglucose uptake by positron emission tomography[J]. Clin Cancer Res,2000, 6(10):3837-3844.
[12] Burt BM, Humm JL, Kooby DA, et al. Using positron emission tomography with[18F] FDG to predict tumor behaviorin experimental colorectal cancer[J]. Neoplasia, 2001, 3(3):189-195.
[13] Borgwardt L, Carstensen H, Schmiegelow K, et al. Increased FDG uptake in childhood CNS tumors is associated with tumor malignancy[J]. Clin Positron Imaging, 2000, 3(4):175.
[14] Brown RS, Leung JY, Kison PV, et al. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer[J]. J Nucl Med, 1999, 40(4):556-565.
[15] Burgman P, Odonoghue JA, Humm JL, et al. Hypoxia-Induced increase in FDG uptake in MCF7 cells[J]. J Nucl Med, 2001,42(1):170-175.
[16] Bentzen L, Keiding S, Horsman MR, et al. Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography[J]. Acta Oncologica, 2000, 39(5):629-637.
[17] Veronesi G, Landoni C, Pelosi G, et al. Fluoro-deoxi-glu-cose uptake and angiogenesis are independent biological features in lung metastases[J]. Br J Cancer, 2002, 86(9):1391-1395.
[18] Bos R, van Der Hoeven JJ, van Der Wall E, et al. Biologic correlates of (18)fluorodexoxyglucose uptake in human breast cancer measured by positron emission tomography[J]. J Clin Oncol, 2002, 20(2):379-387.

相似文献/References:

[1]邵志强,肖耀军,郑少斌.18F-氟代脱氧葡萄糖PET在肾恶性肿瘤中的应用[J].国际放射医学核医学杂志,2006,30(1):24.
　SHAO Zhi-qiang,XIAO Yao-jun,ZHENG Shao-bin.Clinical role of 18F-fluorodeoxyglucose positron emission tomography in renal malignant tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(3):24.
[2]李林法.18F-氟代脱氧葡萄糖正电子发射体层显像在感染与炎症病变中的应用[J].国际放射医学核医学杂志,2006,30(1):26.
　LI Lin-fa.The application of 18F-fluorodeoxyglucose positron emission tomography in infection and inflammation[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(3):26.
[3]张佳胤,李彪.正电子药物在肿瘤诊断中的进展[J].国际放射医学核医学杂志,2006,30(1):30.
　ZHANG Jia-yin,LI Biao.The development of positron emission tomography tracers in the diagnosis of malignant tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(3):30.
[4]朱娴.肿瘤基因-放射治疗的分子机制[J].国际放射医学核医学杂志,2004,28(4):182.
　ZHU Xian.The molecular mechanism of gene-radiotherapy of tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(3):182.
[5]刘道佳,吴君心,唐明灯,等.18F-FLT PET/CT显像评估复发脑胶质瘤患者预后的价值[J].国际放射医学核医学杂志,2018,(5):403.[doi:10.3760/cma.j.issn.1673-4114.2018.05.003]
　Liu Daojia,Wu Junxin,Tang Mingdeng,et al.Prognostic value of 18F-FLT PET/CT imaging in patients with recurrent gliomas[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(3):403.[doi:10.3760/cma.j.issn.1673-4114.2018.05.003]

备注/Memo

备注/Memo:
收稿日期:2003-01-06。
作者简介:李金丽(1976-),女,硕士研究生,主要从事肿瘤放射治疗的研究。;邢力刚(1972-),男,肿瘤学博士研究生,主要从事肿瘤放射治疗方面的研究。
更新日期/Last Update: 1900-01-01